| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
6 companies
Burow Kristina is a Director, 10% Owner at Neumora Therapeutics, Inc. with holdings across 6 companies. Recent SEC Form 4 filings include 22 buys and 2 sells.
Estimated insider holdings value: $117.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 1,915,700 | $2.61 | $4,999,977.00 | +46.4% | -24.2% | - | |
| May 29, 2025 | SRRK Scholar Rock Holding Corp | Director | Sell | 5,400 | $29.72 | $160,510.62 | -10.4% | +15.5% | - | |
| Apr 2, 2024 | BOLD Boundless Bio, Inc. | Director, 10% Owner | Buy | 200,000 | $16.00 | $3,200,000.00 | +12.0% | -69.2% | -89.1% | |
| Nov 14, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 35,010 | $11.77 | $412,139.61 | +0.4% | +52.3% | -9.1% | |
| Nov 10, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 140,605 | $10.98 | $1,543,563.42 | +0.7% | +50.7% | +16.9% | |
| Nov 7, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 95,694 | $11.49 | $1,099,944.70 | +0.8% | +30.9% | +9.6% | |
| Sep 29, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 76,511 | $13.68 | $1,046,848.16 | +0.7% | +21.5% | -8.4% | |
| Sep 27, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 58,504 | $11.97 | $700,464.24 | +0.8% | +48.1% | +10.7% | |
| Sep 25, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 100,740 | $11.19 | $1,127,063.95 | +0.9% | +53.6% | +8.6% | |
| Sep 19, 2023 | NMRA Neumora Therapeutics, Inc. | Director, 10% Owner | Buy | 1,500,000 | $17.00 | $25,500,000.00 | +70.6% | +22.6% | +1.9% |